Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatocellular Carcinoma
"Correlation of Hepatitis Virus Serologic Status with Clinicopathologic Features in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma."
May 26th, 1997
According to the authors' abstract of an article published in Cancer, "Background: This study investigated the relationship between clinicopathologic features and various viral serologies in patients who underwent hepatectomy in the treatment of hepatocellular carcinoma (HCC). Methods: Two hundred two patients were allocated to four groups, according to their positivity or negativity for hepatitis B surface antigen (HBsAg) and hepatitis C virus antibody (HCVAb): Group I (HBsAg-, HCVAb+, n = 151), Group II (HBsAg+, HCVAb-, n = 27), Group III (HBsAg-, HCVAb-, n = 20), or Group IV (HBsAg+,...
Source: Cancer Weekly (1997-05-26)
|
